The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib

.


from Cancer via ola Kala on Inoreader http://ift.tt/2kICDiB
via IFTTT